摘要
以往骨转移癌病人疼痛治疗的常用方法是放疗和阶梯性使用止痛药物。随着核医学的发展 ,亲骨性放射性核素越来越多地用于癌症的治疗 ,尤其是骨转移癌的止痛治疗。其中 ,1 5 3 Sm- EDTMP(1 5 3 Sm-乙二胺四甲撑膦酸 )在缓解疼痛 ,改善生活质量 ,减少新的骨转移病灶发生 。
The typical management of painful bone metastases is radiation therapy and the graduated use of opiate analgesics. As the development of nuclear medicine,bone seeking radiopharmaceuticals have been utilized in cancer treatment,especially in management painful bone metastases. 153 Sm EDTMP (samarium 153 ethylenediaminetetramethylene phosphonate) offers a good choice of treating method in palliating pain, improving quality of life, decreasing the rate at which new painful sites develop, and decreasing management costs.
出处
《国外医学（放射医学核医学分册）》
2000年第3期113-116,共4页
Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
